President Donald Trump taps Scott Gottlieb, an American Enterprise Institute fellow, to run the Food and Drug Administration.
In a speech to Congress, President Donald Trump called the drug approval process at FDA "slow and burdensome."
A floated budget plan could see non-military discretionary spending in the US — which includes science agency funding — fall, the New York Times reports.
Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.
A candidate to be President Donald Trump's science advisor supports limiting federal researchers' ability to discuss their findings, the Guardian reports.
Vox reports that recent policy shifts have led to confusion and uncertainty at the US Food and Drug Administration.
The Wall Street Journal reports that Rep. Tom Price, the pick to lead the Department of Health and Human Services, bought stock in a pharma firm at a special price.
The US immigration ban is already having an effect on US science, the New Scientist says.
Stat News writes that the new executive order on government regulations could affect the 21st Century Cures Act.
Stat News reports that Joseph Gulfo is another contender for FDA commissioner.
The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.
The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.
News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.
In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.